Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05833230 · ClinicalTrials.gov registry record · NA
Investigating Real-world Stress-related Mechanisms in Heavy Cannabis Users
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT05833230 is a NA study that has completed, run by Yale University. The registered enrollment target is 54 participants.
The verdict
NCT05833230, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
This research project proposes a novel approach to elucidate the biological adaptations associated with heavy cannabis use and to assess whether such adaptations are predictive of higher cannabis craving in response to both cannabis cues and stressors.
Interventions
- OTHER Intensive Day Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05833230
The ClinicalTrials.gov registry entry for NCT05833230 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intensive Day Monitoring is the first listed.
NCT05833230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05833230 about?
NCT05833230 is a clinical study titled "Investigating Real-world Stress-related Mechanisms in Heavy Cannabis Users". This research project proposes a novel approach to elucidate the biological adaptations associated with heavy cannabis use and to assess whether such adaptations are predictive of higher cannabis craving in response to both cannabis cues and stressors.
What is the current status of trial NCT05833230?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2023-06-01. Estimated completion is 2025-02-26.
What interventions are being tested in trial NCT05833230?
The interventions under investigation include: Intensive Day Monitoring (OTHER).
Who is sponsoring clinical trial NCT05833230?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.